Dr Mike Dillon | Research Associate
Genentech

Appearances:

Day 2 Antibody Congress @ 11:41

Optimizing antibody expression by using the naturally occurring framework diversity in a live bacterial antibody display system

Plenary

• Bispecific antibodies have gained increased relevance in research and therapeutic settings despite the complexities in their production and challenges in finding the right combination.
• The presentation will discuss strategies and consideration to screen for the best bispecific antibody pair.
• In addition, a novel approach to produce a bispecific antibody with natural architecture in a single cell will be discussed. The technology now simplifies bispecific production for research and development.

Dr Mike Dillon, Research Associate, Genentech